{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:04:46Z","timestamp":1791497086852,"version":"4.3.4"},"reference-count":115,"publisher":"Radiation Research Society","issue":"6","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bioone.org\/page\/resources\/researchers\/rights_and_permissions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2018,8,30]]},"DOI":"10.1667\/rr15137.1","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:09:10Z","timestamp":1535638150000},"page":"659","source":"Crossref","is-referenced-by-count":34,"title":["Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease Treatments"],"prefix":"10.1667","volume":"190","author":[{"given":"Andrea L.","family":"DiCarlo","sequence":"first","affiliation":[{"name":"Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Cassatt","sequence":"additional","affiliation":[{"name":"Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Dowling","sequence":"additional","affiliation":[{"name":"Office of Biodefense Research Resources and Translational Research (OBRRTR), Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Esker","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Office of Biodefense Research Resources and Translational Research (OBRRTR), Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Selivanova","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Williams","sequence":"additional","affiliation":[{"name":"Office of Biodefense Research Resources and Translational Research (OBRRTR), Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Price","sequence":"additional","affiliation":[{"name":"Office of Regulatory Affairs (ORA), DAIT, NIAID, NIH, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"1","unstructured":"\"Guidance for Industry.\"  \"Product Development under the Animal Rule\" (2015)"},{"key":"2","doi-asserted-by":"crossref","unstructured":"A, DiCarlo, R, Tamarat, C, Rios, et al.  \"Radiat Res.\"  188, \"Cellular therapies for treatment of radiation injury: Report from an NIH\/NIAID and IRSN Workshop\" e54 (2017)","DOI":"10.1667\/RR14810.1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"AL, DiCarlo, RJ, Hatchett, JM, Kaminski, et al.  \"Radiat Res.\"  169, \"Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and\/or sepsis. Report of an NIAID Workshop, March 26\u201327, 2007\" 712 (2008)","DOI":"10.1667\/RR1295.1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"AL, DiCarlo, IL, Jackson, JR, Shah, et al.  \"Radiat Res.\"  177, \"Development and licensure of medical countermeasures to treat lung damage resulting from a radiological or nuclear incident\" 717 (2012)","DOI":"10.1667\/RR2881.1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"AL, DiCarlo, M, Poncz, DR, Cassatt, et al.  \"Radiat Res.\"  176, \"Medical countermeasures for platelet regeneration after radiation exposure. Report of a workshop and guided discussion sponsored by the National Institute of Allergy and Infectious Diseases, Bethesda, MD, March 22\u201323, 2010\" e0001 (2011)","DOI":"10.1667\/RROL01.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"A, Papapetropoulos  and C. Szabo  \"Br J Pharmacol.\"  175, \"Inventing new therapies without reinventing the wheel: the power of drug repurposing\" 165 (2018)","DOI":"10.1111\/bph.14081"},{"key":"7","unstructured":"\"Drug repurposing and repositioning: Workshop summary\" (2014)"},{"key":"8","doi-asserted-by":"crossref","unstructured":"\"EBioMedicine.\"  2, \"New indications and a sense of (re)purpose\" 1257 (2015)","DOI":"10.1016\/j.ebiom.2015.10.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"J, Langedijk, AK, Mantel-Teeuwisse, DS, Slijkerman, et al.  \"Drug Discov Today.\"  20, \"Drug repositioning and repurposing: terminology and definitions in literature\" 1027 (2015)","DOI":"10.1016\/j.drudis.2015.05.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"NC, Baker, S, Ekins, AJ, Williams, et al.  \"Drug Discov Today.\"  23, \"A bibliometric review of drug repurposing\" 661 (2018)","DOI":"10.1016\/j.drudis.2018.01.018"},{"key":"11","doi-asserted-by":"crossref","unstructured":"SH, Sleigh  and CL. Barton  \"Pharm Med.\"  24, \"Repurposing strategies for therapeutics\" 151 (2010)","DOI":"10.1007\/BF03256811"},{"key":"12","doi-asserted-by":"crossref","unstructured":"TT, Ashburn  and KB. Thor  \"Nat Rev Drug Discov.\"  3, \"Drug repositioning: identifying and developing new uses for existing drugs\" 673 (2004)","DOI":"10.1038\/nrd1468"},{"key":"13","unstructured":"\"Prepositioning antibiotics for anthrax.\"  \"Committee on Prepositioned Medical Countermeasures for the Public; Institute of Medicine\" (2011)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"JK, Waselenko, TJ, MacVittie, WF, Blakely, et al.  \"Ann Intern Med.\"  140, \"Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group\" 1037 (2004)","DOI":"10.7326\/0003-4819-140-12-200406150-00015"},{"key":"15","unstructured":"\"FDA\/CDER SBIA Chronicles: Patents and exclusivity\" (2015)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"D, Hare  and T. Foster  \"Am Pharm.\"  \"The orange book: the Food and Drug Administration's advice on therapeutic equivalence\" 35 (1990)","DOI":"10.1016\/S0160-3450(16)33557-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"AD, Sabatelli  and CJ. Alpha-Cobb  \"The new FDA purple book for biologics: what does the future hold? Pharm Pat Anal.\"  4, \"Will purple become the new orange?\" 63 (2015)","DOI":"10.4155\/ppa.14.58"},{"key":"18","doi-asserted-by":"crossref","unstructured":"TT. Le,  \"Adv Exp Med Biol.\"  1031, \"Incentivizing orphan product development: United States Food and Drug Administration orphan incentive programs\" 183 (2017)","DOI":"10.1007\/978-3-319-67144-4_10"},{"key":"19","doi-asserted-by":"crossref","unstructured":"N, Hafer, D, Cassatt, A, Dicarlo, et al.  \"Health Phys.\"  98, \"NIAID\/NIH radiation\/nuclear medical countermeasures product research and development program\" 903 (2010)","DOI":"10.1097\/HP.0b013e3181bbc4df"},{"key":"20","doi-asserted-by":"crossref","unstructured":"CI, Rios, DR, Cassatt, AL, Dicarlo, et al.  \"Drug Dev Res.\"  75, \"Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program\" 23 (2014)","DOI":"10.1002\/ddr.21163"},{"key":"21","unstructured":"MW, Epperly, D, Franicola, D, Shields, et al.  \"In Vivo.\"  24, \"Screening of antimicrobial agents for in vitro radiation protection and mitigation capacity, including those used in supportive care regimens for bone marrow transplant recipients\" 9 (2010)"},{"key":"22","doi-asserted-by":"crossref","unstructured":"JG, Kiang  and R. Fukumoto  \"Health Phys.\"  106, \"Ciprofloxacin increases survival after ionizing irradiation combined injury: gamma-H2AX formation, cytokine\/chemokine, and red blood cells\" 720 (2014)","DOI":"10.1097\/HP.0000000000000108"},{"key":"23","doi-asserted-by":"crossref","unstructured":"C, Chen, S, Yang, M, Zhang, et al.  \"Cancer Biol Ther.\"  17, \"Triptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts\" 381 (2016)","DOI":"10.1080\/15384047.2016.1139229"},{"key":"24","doi-asserted-by":"crossref","unstructured":"SO, Piryani, AYF, Kam, EG, Kliassov, et al.  \"Stem Cells.\"  36, \"Epidermal growth factor and granulocyte colony stimulating factor signaling are synergistic for hematopoietic regeneration\" 252 (2018)","DOI":"10.1002\/stem.2731"},{"key":"25","doi-asserted-by":"crossref","unstructured":"PL, Doan, HA, Himburg, K, Helms, et al.  \"Nat Med.\"  19, \"Epidermal growth factor regulates hematopoietic regeneration after radiation injury\" 295 (2013)","DOI":"10.1038\/nm.3070"},{"key":"26","doi-asserted-by":"crossref","unstructured":"H, Sun, Y, Tsai, I, Nowak, et al.  \"Stem Cell Res.\"  9, \"a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem\/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis\" 77 (2012)","DOI":"10.1016\/j.scr.2012.05.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"SA, Peslak, J, Wenger, JC, Bemis, et al.  \"Blood.\"  120, \"EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress\" 2501 (2012)","DOI":"10.1182\/blood-2011-11-394304"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Q, Fu, M, Berbee, W, Wang, et al.  \"Radiat Res.\"  175, \"Preclinical evaluation of Som230 as a radiation mitigator in a mouse model: postexposure time window and mechanisms of action\" 728 (2011)","DOI":"10.1667\/RR2507.1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"M, Boerma, J, Wang, AF, Burnett, et al.  \"Cancer Res.\"  67, \"Local administration of interleukin-11 ameliorates intestinal radiation injury in rats\" 9501 (2007)","DOI":"10.1158\/0008-5472.CAN-07-0810"},{"key":"30","doi-asserted-by":"crossref","unstructured":"AF, Burnett, PG, Biju, H, Lui, et al.  \"Radiat Res.\"  180, \"Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model\" 595 (2013)","DOI":"10.1667\/RR13330.1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"N, Guo, WQ, Wang, XJ, Gong, et al.  \"World J Clin Oncol.\"  8, \"Study of recombinant human interleukin-12 for treatment of complications after radiotherapy for tumor patients\" 158 (2017)","DOI":"10.5306\/wjco.v8.i2.158"},{"key":"32","doi-asserted-by":"crossref","unstructured":"JP, Williams, E, Hernady, CJ, Johnston, et al.  \"Radiat Res.\"  161, \"Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model\" 560 (2004)","DOI":"10.1667\/RR3168"},{"key":"33","doi-asserted-by":"crossref","unstructured":"J, Kharofa, EP, Cohen, R, Tomic, et al.  \"Int J Radiat Oncol Biol Phys.\"  84, \"Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy\" 238 (2012)","DOI":"10.1016\/j.ijrobp.2011.11.013"},{"key":"34","doi-asserted-by":"crossref","unstructured":"F, Gao, BL, Fish, JE, Moulder, et al.  \"Radiat Res.\"  180, \"Enalapril mitigates radiation-induced pneumonitis and pulmonary fibrosis if started 35 days after whole-thorax irradiation\" 546 (2013)","DOI":"10.1667\/RR13350.1"},{"key":"35","doi-asserted-by":"crossref","unstructured":"M, Li, A, Abdollahi, HJ, Grone, et al.  \"Radiat Oncol.\"  4, \"Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model\" 66 (2009)","DOI":"10.1186\/1748-717X-4-66"},{"key":"36","doi-asserted-by":"crossref","unstructured":"DM, Thomas, J, Fox, CK. Haston,  \"Int J Radiat Biol.\"  86, \"Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse\" 436 (2010)","DOI":"10.3109\/09553001003674863"},{"key":"37","unstructured":"H. Branswell,  \"Sci Am.\"  \"Ebola free-for-all could trigger bad science and wasted efforts\" (2014)"},{"key":"38","doi-asserted-by":"crossref","unstructured":"M. Enserink,  \"Science.\"  345, \"Infectious diseases. Debate erupts on \u2018repurposed' drugs for Ebola\" 718 (2014)","DOI":"10.1126\/science.345.6198.718"},{"key":"39","doi-asserted-by":"crossref","unstructured":"JM, Doll, PS, Zeitz, P, Ettestad, et al.  \"Am J Trop Med Hyg.\"  51, \"Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona\" 109 (1994)","DOI":"10.4269\/ajtmh.1994.51.109"},{"key":"40","doi-asserted-by":"crossref","unstructured":"RC, Layton, W, Mega, JD, McDonald, et al.  \"PLoS Negl Trop Dis.\"  5, \"Levofloxacin cures experimental pneumonic plague in African green monkeys\" e959 (2011)","DOI":"10.1371\/journal.pntd.0000959"},{"key":"41","doi-asserted-by":"crossref","unstructured":"AR, Glynn, DA, Alves, O, Frick, et al.  \"Comp Immunol Microbiol Infect Dis.\"  39, \"Comparison of experimental respiratory tularemia in three nonhuman primate species\" 13 (2015)","DOI":"10.1016\/j.cimid.2015.01.003"},{"key":"42","doi-asserted-by":"crossref","unstructured":"WD, Sawyer, HG, Dangerfield, AL, Hogge, et al.  \"Bacteriol Rev.\"  30, \"Antibiotic prophylaxis and therapy of airborne tularemia\" 542 (1966)","DOI":"10.1128\/MMBR.30.3.542-550.1966"},{"key":"43","doi-asserted-by":"crossref","unstructured":"JW, Um, HB, Nygaard, JK, Heiss, et al.  \"Nat Neurosci.\"  15, \"Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons\" 1227 (2012)","DOI":"10.1038\/nn.3178"},{"key":"44","doi-asserted-by":"crossref","unstructured":"AC, Kaufman, SV, Salazar, LT, Haas, et al.  \"Ann Neurol.\"  77, \"Fyn inhibition rescues established memory and synapse loss in Alzheimer mice\" 953 (2015)","DOI":"10.1002\/ana.24394"},{"key":"45","unstructured":"\"Emergency use authorization of medical products and related authorities.\"  (2017)"},{"key":"46","doi-asserted-by":"crossref","unstructured":"AM, Farese, MV, Cohen, BP, Katz, et al.  \"Health Phys.\"  103, \"A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management\" 367 (2012)","DOI":"10.1097\/HP.0b013e31825f75a7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"AM, Farese, MV, Cohen, BP, Katz, et al.  \"Radiat Res.\"  179, \"Filgrastim improves survival in lethally irradiated nonhuman primates\" 89 (2013)","DOI":"10.1667\/RR3049.1"},{"key":"48","unstructured":"L, Ma, GM, Williams, Y, Ouyang, et al.  \"ASCPT 2016 Annual Meeting.\"  \"Patients with hematopoietic syndrome of acute radiation syndrome (HS-ARS): Considerations on the dose selection for filgrastim under the animal rule\" (2016)"},{"key":"49","doi-asserted-by":"crossref","unstructured":"KG, Hankey, AM, Farese, EC, Blaauw, et al.  \"Radiat Res.\"  183, \"Pegfilgrastim improves survival of lethally irradiated nonhuman primates\" 643 (2015)","DOI":"10.1667\/RR13940.1"},{"key":"50","doi-asserted-by":"crossref","unstructured":"VM, Ranieri, BT, Thompson, PS, Barie, et al.  \"N Engl J Med.\"  366, \"Drotrecogin alfa (activated) in adults with septic shock\" 2055 (2012)","DOI":"10.1056\/NEJMoa1202290"},{"key":"51","doi-asserted-by":"crossref","unstructured":"JH, Griffin, BV, Zlokovic, LO. Mosnier,  \"Blood.\"  125, \"Activated protein C: biased for translation\" 2898 (2015)","DOI":"10.1182\/blood-2015-02-355974"},{"key":"52","doi-asserted-by":"crossref","unstructured":"JH, Griffin, JA, Fernandez, LO, Mosnier, et al.  \"Blood Cells Mol Dis.\"  36, \"The promise of protein C\" 211 (2006)","DOI":"10.1016\/j.bcmd.2005.12.023"},{"key":"53","doi-asserted-by":"crossref","unstructured":"H, Geiger, SA, Pawar, EJ, Kerschen, et al.  \"Nat Med.\"  18, \"Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity\" 1123 (2012)","DOI":"10.1038\/nm.2813"},{"key":"54","doi-asserted-by":"crossref","unstructured":"A, Aurora, A, Beasy, JA, Rizzo, et al.  \"J Burn Care Res.\"  39, \"The use of a silver-nylon dressing during evacuation of military burn casualties\" 593 (2018)","DOI":"10.1093\/jbcr\/irx026"},{"key":"55","doi-asserted-by":"crossref","unstructured":"LB, To, JP, Levesque, KE. Herbert,  \"Blood.\"  118, \"How I treat patients who mobilize hematopoietic stem cells poorly\" 4530 (2011)","DOI":"10.1182\/blood-2011-06-318220"},{"key":"56","doi-asserted-by":"crossref","unstructured":"JF, DiPersio, IN, Micallef, PJ, Stiff, et al.  \"J Clin Oncol.\"  27, \"Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma\" 4764 (2009)","DOI":"10.1200\/JCO.2008.20.7209"},{"key":"57","doi-asserted-by":"crossref","unstructured":"AM, Farese, CR, Brown, CP, Smith, et al.  \"Health Phys.\"  106, \"The ability of filgrastim to mitigate mortality following LD50\/60 total-body irradiation is administration time-dependent\" 39 (2014)","DOI":"10.1097\/HP.0b013e3182a4dd2c"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Z, Gluzman-Poltorak, V, Vainstein, LA. Basile,  \"Am J Hematol.\"  89, \"Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure\" 868 (2014)","DOI":"10.1002\/ajh.23770"},{"key":"59","unstructured":"\"Determining whether to submit an ANDA or a 505(b)(2) application: Guidance for industry.\"  (2017)"},{"key":"60","doi-asserted-by":"crossref","unstructured":"M, Christofidou-Solomidou, RA, Pietrofesa, E, Arguiri, et al.  \"Radiat Res.\"  188, \"Radiation mitigating properties of intranasally administered KL4 surfactant in a murine model of radiation-induced lung damage\" 491 (2017)","DOI":"10.1667\/RR14686.1"},{"key":"61","doi-asserted-by":"crossref","unstructured":"MR, Hurle, L, Yang, Q, Xie, et al.  \"Clin Pharmacol Ther.\"  93, \"Computational drug repositioning: from data to therapeutics\" 335 (2013)","DOI":"10.1038\/clpt.2013.1"},{"key":"62","doi-asserted-by":"crossref","unstructured":"JA, Lee, P, Shinn, S, Jaken, et al.  \"PLOS One.\"  10, \"Novel phenotypic outcomes identified for a public collection of approved drugs from a publicly accessible panel of assays\" e0130796 (2015)","DOI":"10.1371\/journal.pone.0130796"},{"key":"63","doi-asserted-by":"crossref","unstructured":"KA, Houck, DJ, Dix, RS, Judson, et al.  \"J Biomol Screen.\"  14, \"Profiling bioactivity of the ToxCast chemical library using BioMAP primary human cell systems\" 1054 (2009)","DOI":"10.1177\/1087057109345525"},{"key":"64","doi-asserted-by":"crossref","unstructured":"CM, Taniguchi, YR, Miao, AN, Diep, et al.  \"Sci Transl Med.\"  6, \"PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2\" (2014)","DOI":"10.1126\/scitranslmed.3008523"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Y, Peng, M, Zhang, L, Zheng, et al.  \"Nature.\"  547, \"Cysteine protease cathepsin B mediates radiation-induced bystander effects\" 458 (2017)","DOI":"10.1038\/nature23284"},{"key":"66","doi-asserted-by":"crossref","unstructured":"J, Gu, S, Liu, N, Mu, et al.  \"J Control Release.\"  260, \"A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury\" 32 (2017)","DOI":"10.1016\/j.jconrel.2017.05.020"},{"key":"67","doi-asserted-by":"crossref","unstructured":"L, Wei, BJ, Leibowitz, X, Wang, et al.  \"J Clin Invest.\"  126, \"Inhibition of CDK4\/6 protects against radiation-induced intestinal injury in mice\" 4076 (2016)","DOI":"10.1172\/JCI88410"},{"key":"68","doi-asserted-by":"crossref","unstructured":"EP, Cohen, BL, Fish, JE. Moulder,  \"Radiat Res.\"  185, \"Clinically relevant doses of enalapril mitigate multiple organ radiation injury\" 313 (2016)","DOI":"10.1667\/RR4243.S1"},{"key":"69","doi-asserted-by":"crossref","unstructured":"M, Holecki, J, Szewieczek, J. Chudek,  \"Pharmacol Rep.\"  63, \"Effects of angiotensin-converting enzyme inhibitors beyond lowering blood pressure\u2013are they important for doctors?\" 740 (2011)","DOI":"10.1016\/S1734-1140(11)70586-2"},{"key":"70","doi-asserted-by":"crossref","unstructured":"WF, Ward, YT, Kim, A, Molteni, et al.  \"Int J Radiat Oncol Biol Phys.\"  15, \"Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme\" 135 (1988)","DOI":"10.1016\/0360-3016(88)90357-4"},{"key":"71","doi-asserted-by":"crossref","unstructured":"JE, Moulder, EP, Cohen, BL. Fish,  \"Int J Radiat Biol.\"  90, \"Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors\" 762 (2014)","DOI":"10.3109\/09553002.2014.938375"},{"key":"72","doi-asserted-by":"crossref","unstructured":"JE, Moulder, EP, Cohen, BL. Fish,  \"Radiat Res.\"  175, \"Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation\" 29 (2011)","DOI":"10.1667\/RR2400.1"},{"key":"73","doi-asserted-by":"crossref","unstructured":"L, Kma, F, Gao, BL, Fish, et al.  \"J Radiat Res.\"  53, \"Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax\" 10 (2012)","DOI":"10.1269\/jrr.11035"},{"key":"74","doi-asserted-by":"crossref","unstructured":"BL, Fish, F, Gao, J, Narayanan, et al.  \"Health Phys.\"  111, \"Combined hydration and antibiotics with lisinopril to mitigate acute and delayed high-dose radiation injuries to multiple organs\" 410 (2016)","DOI":"10.1097\/HP.0000000000000554"},{"key":"75","doi-asserted-by":"crossref","unstructured":"RR, Kohl, A, Kolozsvary, SL, Brown, et al.  \"Radiat Res.\"  168, \"Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor\" 440 (2007)","DOI":"10.1667\/RR0707.1"},{"key":"76","doi-asserted-by":"crossref","unstructured":"F, Gao, BL, Fish, A, Szabo, et al.  \"Int J Radiat Biol.\"  90, \"Enhanced survival from radiation pneumonitis by combined irradiation to the skin\" 753 (2014)","DOI":"10.3109\/09553002.2014.922722"},{"key":"77","doi-asserted-by":"crossref","unstructured":"KA, Jenrow, SL, Brown, J, Liu, et al.  \"Radiat Oncol.\"  5, \"Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus\" 6 (2010)","DOI":"10.1186\/1748-717X-5-6"},{"key":"78","doi-asserted-by":"crossref","unstructured":"KA, Jenrow, J, Liu, SL, Brown, et al.  \"J Neurooncol.\"  101, \"Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis\" 449 (2011)","DOI":"10.1007\/s11060-010-0282-x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"SN, Ghosh, R, Zhang, BL, Fish, et al.  \"Int J Radiat Oncol Biol Phys.\"  75, \"Renin-angiotensin system suppression mitigates experimental radiation pneumonitis\" 1528 (2009)","DOI":"10.1016\/j.ijrobp.2009.07.1743"},{"key":"80","doi-asserted-by":"crossref","unstructured":"M, Medhora, F, Gao, BL, Fish, et al.  \"J Radiat Res.\"  53, \"Dose-modifying factor for captopril for mitigation of radiation injury to normal lung\" 633 (2012)","DOI":"10.1093\/jrr\/rrs004"},{"key":"81","doi-asserted-by":"crossref","unstructured":"EP, Cohen, M, Bedi, AA, Irving, et al.  \"Int J Radiat Oncol Biol Phys.\"  83, \"Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation\" 292 (2012)","DOI":"10.1016\/j.ijrobp.2011.05.081"},{"key":"82","doi-asserted-by":"crossref","unstructured":"JP, Mochel, M, Fink, M, Peyrou, et al.  \"Pharm Res.\"  32, \"Pharmacokinetic\/pharmacodynamic modeling of renin-angiotensin aldosterone biomarkers following angiotensin-converting enzyme (ACE) inhibition therapy with benazepril in dogs\" 1931 (2015)","DOI":"10.1007\/s11095-014-1587-9"},{"key":"83","doi-asserted-by":"crossref","unstructured":"M, Bohnert, HW, Nutzmann, V, Schroeckh, et al.  \"Phytochemistry.\"  105, \"Cytotoxic and antifungal activities of melleolide antibiotics follow dissimilar structure-activity relationships\" 101 (2014)","DOI":"10.1016\/j.phytochem.2014.05.009"},{"key":"84","doi-asserted-by":"crossref","unstructured":"AM, Sugar, XP, Liu, RJ. Chen,  \"Antimicrob Agents Chemother.\"  41, \"Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs\" 2518 (1997)","DOI":"10.1128\/AAC.41.11.2518"},{"key":"85","doi-asserted-by":"crossref","unstructured":"FE, Nwariaku, KL, McIntyre, PJ, Sikes, et al.  \"J Antimicrob Chemother.\"  39, \"The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin\" 265 (1997)","DOI":"10.1093\/jac\/39.2.265"},{"key":"86","doi-asserted-by":"crossref","unstructured":"K, Riesbeck, J, Andersson, M, Gullberg, et al.  \"Proc Natl Acad Sci U S A.\"  86, \"Fluorinated 4-quinolones induce hyperproduction of interleukin 2\" 2809 (1989)","DOI":"10.1073\/pnas.86.8.2809"},{"key":"87","doi-asserted-by":"crossref","unstructured":"M, Blank, J, George, P, Fishman, et al.  \"Arthritis Rheum.\"  41, \"Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression\" 224 (1998)","DOI":"10.1002\/1529-0131(199802)41:2<224::AID-ART6>3.0.CO;2-W"},{"key":"88","unstructured":"KR, Imrie, HM, Prince, F, Couture, et al.  \"Bone Marrow Transplant.\"  15, \"Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole\" 267 (1995)"},{"key":"89","doi-asserted-by":"crossref","unstructured":"MA, Lew, K, Kehoe, J, Ritz, et al.  \"J Clin Oncol.\"  13, \"Ciprofloxacin versus trimethoprim\/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial\" 239 (1995)","DOI":"10.1200\/JCO.1995.13.1.239"},{"key":"90","doi-asserted-by":"crossref","unstructured":"A, Freifeld, D, Marchigiani, T, Walsh, et al.  \"N Engl J Med.\"  341, \"A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy\" 305 (1999)","DOI":"10.1056\/NEJM199907293410501"},{"key":"91","unstructured":"PS, Henshaw  and AM. Brues  \"Atomic Bomb Casualty Commission: General report. 1947.\"  (1947)"},{"key":"92","doi-asserted-by":"crossref","unstructured":"GD, Ledney  and TB. Elliott  \"Health Phys.\"  98, \"Combined injury: Factors with potential to impact radiation dose assessments\" 145 (2010)","DOI":"10.1097\/01.HP.0000348466.09978.77"},{"key":"93","doi-asserted-by":"crossref","unstructured":"JG, Kiang  and GD. Ledney  \"Oxid Med Cell Longev.\"  2013, \"Skin injuries reduce survival and modulate corticosterone, C-reactive protein, complement component 3, IgM, and prostaglandin E 2 after whole-body reactor-produced mixed field (n + gamma-photons) irradiation\" 821541 (2013)","DOI":"10.1155\/2013\/821541"},{"key":"94","unstructured":"Y, Kletter, A, Singer, A, Nagler, et al.  \"Exp Hematol.\"  22, \"Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally irradiated, bone marrow-transplanted mice\" 360 (1994)"},{"key":"95","doi-asserted-by":"crossref","unstructured":"C, Booth, G, Tudor, N, Tonge, et al.  \"Health Phys.\"  103, \"Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice\" 400 (2012)","DOI":"10.1097\/HP.0b013e31826530e2"},{"key":"96","doi-asserted-by":"crossref","unstructured":"C, Sahakitrungruang, S, Thum-Umnuaysuk, A, Patiwongpaisarn, et al.  \"Colorectal Dis.\"  13, \"A novel treatment for haemorrhagic radiation proctitis using colonic irrigation and oral antibiotic administration\" e79 (2011)","DOI":"10.1111\/j.1463-1318.2010.02527.x"},{"key":"97","doi-asserted-by":"crossref","unstructured":"R, Fukumoto, TM, Burns, JG. Kiang,  \"PLoS One.\"  9, \"Ciprofloxacin enhances stress erythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound trauma\" e90448 (2014)","DOI":"10.1371\/journal.pone.0090448"},{"key":"98","doi-asserted-by":"crossref","unstructured":"TB, Elliott, DL, Bolduc, GD, Ledney, et al.  \"Int J Radiat Biol.\"  91, \"Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice\" 690 (2015)","DOI":"10.3109\/09553002.2015.1054526"},{"key":"99","doi-asserted-by":"crossref","unstructured":"AD, Augustine, T, Gondre-Lewis, W, McBride, et al.  \"Radiat Res.\"  164, \"Animal models for radiation injury, protection and therapy\" 100 (2005)","DOI":"10.1667\/RR3388"},{"key":"100","doi-asserted-by":"crossref","unstructured":"DB. Ridley,  \"Am J Trop Med Hyg.\"  96, \"Priorities for the priority review voucher\" 14 (2017)","DOI":"10.4269\/ajtmh.16-0600"},{"key":"101","unstructured":"\"FDA takes steps to spur development of medical countermeasures needed to protect, prepare for emerging threats to public health and national security\" (2017)"},{"key":"102","unstructured":"\"Guidance for industry (DRAFT).\"  \"Material threat medical countermeasure priority review vouchers\" (2018)"},{"key":"103","doi-asserted-by":"crossref","unstructured":"DB, Ridley  and SA. Regnier  \"Health Aff (Millwood).\"  35, \"The commercial market for priority review vouchers\" 776 (2016)","DOI":"10.1377\/hlthaff.2015.1314"},{"key":"104","doi-asserted-by":"crossref","unstructured":"N, Hafer, BW, Maidment, RJ. Hatchett,  \"Biosecur Bioterror.\"  8, \"The NIAID Radiation Countermeasures Program business model\" 357 (2010)","DOI":"10.1089\/bsp.2010.0041"},{"key":"105","doi-asserted-by":"crossref","unstructured":"A, Meyerhoff, R, Albrecht, JM, Meyer, et al.  \"Clin Infect Dis.\"  39, \"Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax\" 303 (2004)","DOI":"10.1086\/421491"},{"key":"106","doi-asserted-by":"crossref","unstructured":"R, Fukumoto, LH, Cary, NV, Gorbunov, et al.  \"PLoS One.\"  8, \"Ciprofloxacin modulates cytokine\/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound trauma\" e58389 (2013)","DOI":"10.1371\/journal.pone.0058389"},{"key":"107","unstructured":"M O'Rourke,  \"AIDS Clin Care.\"  17(11), \"FDA approves generic AZT for U.S. market.\" 108 (2005)"},{"key":"108","doi-asserted-by":"crossref","unstructured":"GL North,  \"Ann Pharmacother.\"  35(12), \"Celecoxib as adjunctive therapy for treatment of\ncolorectal cancer.\" 1638 (2001)","DOI":"10.1345\/aph.10133"},{"key":"109","doi-asserted-by":"crossref","unstructured":"J Li, SG Kim, J Blenis,  \"Cell Metab.\"  19(3), \"Rapamycin: one drug, many effects.\" 373 (2014)","DOI":"10.1016\/j.cmet.2014.01.001"},{"key":"110","doi-asserted-by":"crossref","unstructured":"I Torjesen,  \"BMJ.\"  347, \"Avastin is as effective as Lucentis in treating wet age related macular degeneration, study finds.\" f4678 (2013)","DOI":"10.1136\/bmj.f4678"},{"key":"111","doi-asserted-by":"crossref","unstructured":"BM Heckman-Stoddard, A DeCensi, VV Sahasrabuddhe, et al.  \"Diabetologia.\"  60(9), \"Repurposing metformin for the prevention of cancer and cancer recurrence.\" 1639 (2017)","DOI":"10.1007\/s00125-017-4372-6"},{"key":"112","doi-asserted-by":"crossref","unstructured":"TG Kreindler,  \"Journal of the American Academy of Dermatology.\"  16(3 Pt\n2), \"Topical minoxidil in early androgenetic alopecia.\" 718 (1987)","DOI":"10.1016\/S0190-9622(87)70093-0"},{"key":"113","unstructured":"I Ahmed,  \"Mo Med.\"  99(9), \"Ropinirole in restless leg syndrome.\" 500 (2002)"},{"key":"114","doi-asserted-by":"crossref","unstructured":"J Sheskin,  \"Clin Pharmacol Ther.\"  6, \"Thalidomide in the treatment of lepra reactions.\" 303 (1965)","DOI":"10.1002\/cpt196563303"},{"key":"115","doi-asserted-by":"crossref","unstructured":"JB Bartlett, K Dredge, AG Dalgleish,  \"Nat Rev Cancer.\"  4(4), \"The evolution of thalidomide and its IMiD derivatives as anticancer agents.\" 314 (2004)","DOI":"10.1038\/nrc1323"}],"container-title":["Radiation Research"],"original-title":[],"link":[{"URL":"http:\/\/www.bioone.org\/doi\/full-xml\/10.1667\/RR15137.1","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T04:10:32Z","timestamp":1631247032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-190\/issue-6\/RR15137.1\/Challenges-and-Benefits-of-Repurposing-Products-for-Use-during-a\/10.1667\/RR15137.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":115,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rr15137.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,30]]}}}